Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α‐XBP1 pathway - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Neuropathology and Applied Neurobiology Année : 2022

Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α‐XBP1 pathway

Résumé

Abstract Aim Spinal muscular atrophy (SMA) is a neuromuscular disease caused by survival of motor neuron (SMN) deficiency that induces motor neuron (MN) degeneration and severe muscular atrophy. Gene therapies that increase SMN have proven their efficacy but not for all patients. Here, we explored the unfolded protein response (UPR) status in SMA pathology and explored whether UPR modulation could be beneficial for SMA patients. Methods We analysed the expression and activation of key UPR proteins by RT‐qPCR and by western blots in SMA patient iPSC‐derived MNs and one SMA cell line in which SMN expression was re‐established (rescue). We complemented this approach by using myoblast and fibroblast SMA patient cells and SMA mouse models of varying severities. Finally, we tested in vitro and in vivo the effect of IRE1α/XBP1 pathway restoration on SMN expression and subsequent neuroprotection. Results We report that the IRE1α/XBP1 branch of the unfolded protein response is disrupted in SMA, with a depletion of XBP1s irrespective of IRE1α activation pattern. The overexpression of XBP1s in SMA fibroblasts proved to transcriptionally enhance SMN expression. Importantly, rebalancing XBP1s expression in severe SMA‐like mice, induced SMN expression and spinal MN protection. Conclusions We have identified XBP1s depletion as a contributing factor in SMA pathogenesis, and the modulation of this transcription factor proves to be a plausible therapeutic avenue in the context of pharmacological interventions for patients.
Fichier principal
Vignette du fichier
Neuropathology Appl Neurobio - 2022 - D'Amico - Activating ATF6 in spinal muscular atrophy promotes SMN expression and.pdf (16.98 Mo) Télécharger le fichier
Origine Publication financée par une institution
Licence

Dates et versions

inserm-04385529 , version 1 (10-01-2024)

Licence

Identifiants

Citer

Domenico d'Amico, Olivier Biondi, Camille Januel, Cynthia Bezier, Delphine Sapaly, et al.. Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α‐XBP1 pathway. Neuropathology and Applied Neurobiology, 2022, 48 (5), pp.e12816. ⟨10.1111/nan.12816⟩. ⟨inserm-04385529⟩
16 Consultations
8 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More